Hormone therapy and Alzheimer’s disease: benefit or harm?

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.2, 2004-02, pp. : 389-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New concepts in the drug therapy of Alzheimer’s disease

By Farlow Martin R Hake Ann Marie

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 1975-1983

Informa Healthcare

Access to resources Recommend Favorite

Editorial: Multitarget Molecules for Alzheimer's Disease Therapy

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3318-3318

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease

By Thompson Sarah Lanctôt Krista L Herrmann Nathan

Expert Opinion on Drug Safety, Vol. 3, Iss. 5, 2004-09 ,pp. : 425-440

Informa Healthcare

Access to resources Recommend Favorite

The Multifunctional Anti-inflammatory Drugs Used in the Therapy of Alzheimer’s Disease

Current Medicinal Chemistry, Vol. 20, Iss. 20, 2013-07 ,pp. : 2583-2588

Bentham Science Publishers

Access to resources Recommend Favorite